DK1965801T3 - Kombination af azd2171 og pemetrexed - Google Patents
Kombination af azd2171 og pemetrexedInfo
- Publication number
- DK1965801T3 DK1965801T3 DK06820574.9T DK06820574T DK1965801T3 DK 1965801 T3 DK1965801 T3 DK 1965801T3 DK 06820574 T DK06820574 T DK 06820574T DK 1965801 T3 DK1965801 T3 DK 1965801T3
- Authority
- DK
- Denmark
- Prior art keywords
- azd2171
- pemetrexed
- human
- combination
- antiangiogenic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0526132A GB0526132D0 (en) | 2005-12-22 | 2005-12-22 | Combination Therapy |
GB0610708A GB0610708D0 (en) | 2006-05-31 | 2006-05-31 | Combination therapy |
PCT/GB2006/004768 WO2007071970A2 (en) | 2005-12-22 | 2006-12-19 | Combination of azd2171 and pemetrexed |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1965801T3 true DK1965801T3 (da) | 2011-06-14 |
Family
ID=37964934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06820574.9T DK1965801T3 (da) | 2005-12-22 | 2006-12-19 | Kombination af azd2171 og pemetrexed |
Country Status (20)
Country | Link |
---|---|
US (1) | US20080306094A1 (da) |
EP (1) | EP1965801B1 (da) |
JP (1) | JP2009520787A (da) |
KR (1) | KR20080077678A (da) |
AT (1) | ATE502641T1 (da) |
AU (1) | AU2006328201B2 (da) |
BR (1) | BRPI0620118A2 (da) |
CA (1) | CA2631676A1 (da) |
CY (1) | CY1111482T1 (da) |
DE (1) | DE602006020919D1 (da) |
DK (1) | DK1965801T3 (da) |
HK (1) | HK1123976A1 (da) |
HR (1) | HRP20110365T1 (da) |
IL (1) | IL191797A0 (da) |
NO (1) | NO20082566L (da) |
NZ (1) | NZ568812A (da) |
PL (1) | PL1965801T3 (da) |
PT (1) | PT1965801E (da) |
SI (1) | SI1965801T1 (da) |
WO (1) | WO2007071970A2 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0008269D0 (en) * | 2000-04-05 | 2000-05-24 | Astrazeneca Ab | Combination chemotherapy |
GB0406446D0 (en) * | 2004-03-23 | 2004-04-28 | Astrazeneca Ab | Combination therapy |
AU2005225192B2 (en) * | 2004-03-23 | 2008-10-09 | Astrazeneca Ab | Combination therapy |
GB0406445D0 (en) * | 2004-03-23 | 2004-04-28 | Astrazeneca Ab | Combination therapy |
NZ564189A (en) * | 2005-07-06 | 2011-04-29 | Astrazeneca Ab | Combination therapy of cancer with AZD2171 and gemcitabine |
JP5167144B2 (ja) * | 2005-12-22 | 2013-03-21 | アストラゼネカ アクチボラグ | 併用療法 |
US20090221615A1 (en) * | 2008-02-29 | 2009-09-03 | Guru Reddy | Combination anti-cancer agents |
RU2627588C2 (ru) | 2010-03-08 | 2017-08-09 | Спектрум Фармасьютикалз, Инк. | Способы лечения рака с применением ингибитора аутофагии на основе тиоксантона |
KR20180059430A (ko) * | 2015-07-30 | 2018-06-04 | 익스프레션 패톨로지, 인크. | 최적의 암 치료를 위한 FR-α 및 GART 단백질의 정량화 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU762615B2 (en) * | 1998-06-15 | 2003-07-03 | Arch Development Corporation | Combination of radiotherapy and anti-angiogenic factors |
KR20080015482A (ko) * | 1999-02-10 | 2008-02-19 | 아스트라제네카 아베 | 혈관형성 억제제로서의 퀴나졸린 유도체 |
GB0008269D0 (en) * | 2000-04-05 | 2000-05-24 | Astrazeneca Ab | Combination chemotherapy |
GB0310401D0 (en) * | 2003-05-07 | 2003-06-11 | Astrazeneca Ab | Therapeutic agent |
GB0316127D0 (en) * | 2003-07-10 | 2003-08-13 | Astrazeneca Ab | Combination therapy |
GB0316123D0 (en) * | 2003-07-10 | 2003-08-13 | Astrazeneca Ab | Combination therapy |
GB0330002D0 (en) * | 2003-12-24 | 2004-01-28 | Astrazeneca Ab | Quinazoline derivatives |
GB0406446D0 (en) * | 2004-03-23 | 2004-04-28 | Astrazeneca Ab | Combination therapy |
AU2005225192B2 (en) * | 2004-03-23 | 2008-10-09 | Astrazeneca Ab | Combination therapy |
GB0406445D0 (en) * | 2004-03-23 | 2004-04-28 | Astrazeneca Ab | Combination therapy |
WO2005117980A1 (en) * | 2004-06-04 | 2005-12-15 | Pfizer Products Inc. | Method for treating abnormal cell growth |
AU2005288736B2 (en) * | 2004-09-27 | 2008-08-14 | Astrazeneca Ab | Cancer combination therapy comprising AZD2171 and imatinib |
NZ564189A (en) * | 2005-07-06 | 2011-04-29 | Astrazeneca Ab | Combination therapy of cancer with AZD2171 and gemcitabine |
WO2007068895A1 (en) * | 2005-12-15 | 2007-06-21 | Astrazeneca Ab | Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer |
JP5167144B2 (ja) * | 2005-12-22 | 2013-03-21 | アストラゼネカ アクチボラグ | 併用療法 |
-
2006
- 2006-12-19 NZ NZ568812A patent/NZ568812A/en unknown
- 2006-12-19 JP JP2008546594A patent/JP2009520787A/ja active Pending
- 2006-12-19 DE DE602006020919T patent/DE602006020919D1/de active Active
- 2006-12-19 SI SI200631009T patent/SI1965801T1/sl unknown
- 2006-12-19 BR BRPI0620118-0A patent/BRPI0620118A2/pt not_active Application Discontinuation
- 2006-12-19 US US12/158,266 patent/US20080306094A1/en not_active Abandoned
- 2006-12-19 AU AU2006328201A patent/AU2006328201B2/en not_active Ceased
- 2006-12-19 AT AT06820574T patent/ATE502641T1/de active
- 2006-12-19 PT PT06820574T patent/PT1965801E/pt unknown
- 2006-12-19 KR KR1020087016943A patent/KR20080077678A/ko not_active Application Discontinuation
- 2006-12-19 DK DK06820574.9T patent/DK1965801T3/da active
- 2006-12-19 WO PCT/GB2006/004768 patent/WO2007071970A2/en active Application Filing
- 2006-12-19 CA CA002631676A patent/CA2631676A1/en not_active Abandoned
- 2006-12-19 EP EP06820574A patent/EP1965801B1/en active Active
- 2006-12-19 PL PL06820574T patent/PL1965801T3/pl unknown
-
2008
- 2008-05-28 IL IL191797A patent/IL191797A0/en unknown
- 2008-06-02 NO NO20082566A patent/NO20082566L/no not_active Application Discontinuation
-
2009
- 2009-01-19 HK HK09100508.6A patent/HK1123976A1/xx not_active IP Right Cessation
-
2011
- 2011-05-18 HR HR20110365T patent/HRP20110365T1/hr unknown
- 2011-05-20 CY CY20111100490T patent/CY1111482T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2007071970A2 (en) | 2007-06-28 |
NZ568812A (en) | 2011-09-30 |
CY1111482T1 (el) | 2015-08-05 |
KR20080077678A (ko) | 2008-08-25 |
SI1965801T1 (sl) | 2011-06-30 |
IL191797A0 (en) | 2008-12-29 |
BRPI0620118A2 (pt) | 2011-11-01 |
ATE502641T1 (de) | 2011-04-15 |
EP1965801A2 (en) | 2008-09-10 |
AU2006328201B2 (en) | 2010-08-19 |
WO2007071970A3 (en) | 2007-08-09 |
EP1965801B1 (en) | 2011-03-23 |
CA2631676A1 (en) | 2007-06-28 |
DE602006020919D1 (de) | 2011-05-05 |
PT1965801E (pt) | 2011-05-25 |
US20080306094A1 (en) | 2008-12-11 |
JP2009520787A (ja) | 2009-05-28 |
AU2006328201A1 (en) | 2007-06-28 |
NO20082566L (no) | 2008-07-31 |
HK1123976A1 (en) | 2009-07-03 |
HRP20110365T1 (hr) | 2011-06-30 |
PL1965801T3 (pl) | 2011-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1971338T3 (da) | Kombination af ZD6474 og pemetrexed | |
MX2007003505A (es) | Combinacion que comprende zd6474 e imatinib. | |
MX2007003506A (es) | Terapia de combinacion de cancer que comprende azd2171 e imatinib. | |
CY1111482T1 (el) | Συνδυασμος azd2171 και πεμετρεξεδης | |
HRP20080597T3 (en) | Cancer combination therapy comprising azd2171 and zd1839 | |
NO20064755L (no) | Kombinasjonsterapi | |
NO20056171L (no) | Kombinasjonsterapi | |
WO2005092384A3 (en) | Combination therapy with azd2171 and a platinum anti-tumour agent | |
NO20064754L (no) | Kombinasjonsterapi | |
WO2007003933A3 (en) | Combination therapy of cancer with azd2171 and gemcitabine |